The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

While there have been many significant advances in healthcare in the past 25 years, including new treatments for cancer ...

Missing weekly cisplatin cycles was associated with worse OS in patients with head and neck cancers, particularly for those ...

Data analysed by the cancer support charity Macmillan shows roughly half a million more people will be living with cancer by ...

Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific ...

Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering ...

DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

Sixfold increase in NICE's lung cancer treatment recommendations over the past decade. NICE has recommended osimertinib for ...

New figures say there will be 3.4m people living with cancer in the UK by the end of 2025 - but the earlier it is spotted the ...

"EC approves GSK’s Jemperli-chemo combo for endometrial cancer" was originally created and published by Pharmaceutical ...